Millions of people with Medicare are now eligible to get discounted GLP-1 drugs for weight loss under a special program. Here's how it will work.
As Americans are encouraged to go direct with weight-loss drug prescriptions, retail pharmacy chains are poised to win big.
Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
By Amina Niasse NEW YORK, June 11 (Reuters) - Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from ...
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1. Mary Abrahamson hopes to be one of them. The ...
The agreement involves Indiana-based drug manufacturer Eli Lilly.
The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago ...
Survodutide is a dual glucagon/GLP-1 receptor agonist. It’s under investigation by manufacturer Boehringer Ingelheim to treat ...